Watchlist Manager

Watchlist

Price: 2 204 JPY 0.3% Market Closed

Market Cap: ¥877B

	Sumitomo Pharma Co Ltd TSE:4506	JP

Balance Sheet

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	23 971	13 906	20 440	35 190	60 327	55 765	28 168	21 990	13 823	14 938	12 953	18 753	22 746	30 553	54 922	105 603	147 775	137 296	101 708	193 698	202 984	143 478	29 047	23 116
Cash Equivalents	23 971	13 906	20 440	35 190	60 327	55 765	28 168	21 990	13 823	14 938	12 953	18 753	22 746	30 553	54 922	105 603	147 775	137 296	101 708	193 698	202 984	143 478	29 047	23 116
Short-Term Investments	2 648	5 089	4 796	4 510	13 995	27 962	30 086	34 500	51 184	90 921	99 118	86 463	81 952	111 293	81 039	17 494	22 066	43 750	28 717	29 480	35 596	20 174	7 085	16 840
Total Receivables	64 662	66 955	64 322	67 328	114 394	88 543	126 062	129 365	118 789	132 681	126 845	131 478	153 262	151 999	155 587	118 966	113 401	119 243	140 368	136 060	151 500	98 630	97 239	77 726
Accounts Receivables	64 662	66 955	64 322	67 328	114 394	88 543	86 062	79 365	93 789	107 681	101 845	97 077	111 542	102 947	107 161	110 700	110 582	116 059	129 368	128 569	141 020	86 405	68 818	64 963
Other Receivables	0	0	0	0	0	0	40 000	50 000	25 000	25 000	25 000	34 401	41 720	49 052	48 426	8 266	2 819	3 184	11 000	7 491	10 480	12 225	28 421	12 763
Inventory	22 770	24 134	21 808	16 217	44 116	44 954	48 522	54 509	65 229	55 970	58 116	62 689	59 141	62 387	59 587	60 286	60 169	66 889	79 368	92 215	99 021	94 405	115 350	94 222
Other Current Assets	5 194	6 154	7 192	7 929	16 899	17 087	18 220	23 173	38 526	38 487	37 218	34 055	42 510	45 467	70 449	5 211	5 170	6 090	13 929	8 342	10 420	25 173	20 848	41 264
Total Current Assets	119 245	116 238	118 558	131 174	249 731	234 311	251 058	263 537	287 551	332 997	334 250	333 438	359 611	401 699	421 584	307 560	348 581	373 268	364 090	459 795	499 521	381 860	269 569	253 168
PP&E Net	33 638	35 372	34 472	32 609	68 336	65 241	70 279	69 103	74 083	69 792	66 697	69 862	72 689	65 160	61 824	61 121	58 204	59 485	65 748	64 966	64 091	58 909	57 895	46 648
PP&E Gross	33 638	35 372	34 472	32 609	68 336	65 241	70 279	69 103	74 083	69 792	66 697	69 862	72 689	65 160	61 824	61 121	58 204	59 485	65 748	64 966	64 091	58 909	57 895	46 648
Accumulated Depreciation	45 112	46 348	48 559	50 322	108 195	113 806	119 952	123 740	129 240	137 285	141 744	144 152	149 342	148 272	154 453	159 828	161 841	157 542	129 214	122 819	132 888	130 474	129 724	121 251
Intangible Assets	1 458	1 689	4 714	2 977	5 952	6 702	5 849	6 407	115 917	72 896	43 395	75 017	76 127	85 788	79 630	197 114	189 681	171 390	421 029	383 406	398 692	329 314	195 652	172 509
Goodwill	0	0	0	0	0	0	0	0	83 564	70 369	64 311	71 293	80 669	88 075	76 950	100 194	95 097	99 348	173 464	176 492	195 144	209 415	199 783	197 406
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2 453	2 562	0	6 726	5 538	6 042	6 846	6 765
Long-Term Investments	25 398	22 891	32 329	29 486	48 920	52 026	44 340	33 982	54 888	28 122	30 055	41 038	50 823	58 193	60 432	52 681	70 993	74 668	200 923	193 035	115 844	134 007	161 711	49 736
Other Long-Term Assets	7 092	11 220	3 158	5 179	20 023	24 251	28 256	18 259	10 733	15 685	20 702	16 571	19 113	12 668	7 295	60 402	44 675	53 996	31 280	23 707	29 177	15 195	16 050	16 372
Other Assets	0	0	0	0	0	0	0	0	83 564	70 369	64 311	71 293	80 669	88 075	76 950	100 194	95 097	99 348	173 464	176 492	195 144	209 415	199 783	197 406
Total Assets	186 831 N/A	187 410 +0%	193 231 +3%	201 425 +4%	392 962 +95%	382 531 -3%	399 782 +5%	391 288 -2%	626 736 +60%	589 861 -6%	559 410 -5%	607 219 +9%	659 032 +9%	711 583 +8%	707 715 -1%	779 072 +10%	809 684 +4%	834 717 +3%	1 256 534 +51%	1 308 127 +4%	1 308 007 0%	1 134 742 -13%	907 506 -20%	742 604 -18%
Liabilities
Accounts Payable	31 341	31 867	31 429	32 172	38 693	18 036	16 499	18 523	16 878	15 647	16 860	14 253	11 713	12 492	12 153	14 514	17 512	15 498	25 640	26 076	22 455	13 403	20 765	9 225
Accrued Liabilities	4 074	4 196	4 087	4 126	8 050	8 036	8 214	8 120	7 408	7 431	7 592	7 610	7 786	0	10 809	0	0	0	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	0	0	165 800	50 000	0	0	0	0	1 010	40 000	3 500	0	270 000	5 000	5 025	90 588	174 588	42 440
Current Portion of Long-Term Debt	0	11 118	0	0	0	0	4 600	0	0	10 600	10 000	20 000	10 000	36 522	22 000	18 000	12 960	3 697	9 097	11 019	25 832	4 660	114 710	7 354
Other Current Liabilities	14 368	14 323	11 194	13 675	33 325	29 965	38 598	26 703	74 911	73 522	71 514	82 968	101 708	98 413	133 750	159 619	176 276	178 979	191 761	236 052	225 061	264 043	205 411	181 584
Total Current Liabilities	49 783	61 504	46 710	49 973	80 068	56 037	67 911	53 346	264 997	157 200	105 966	124 831	131 207	156 843	179 722	232 133	210 248	198 174	496 498	278 147	278 373	372 694	515 474	240 603
Long-Term Debt	11 118	0	7 000	7 000	5 275	4 600	0	0	0	93 000	118 000	95 000	85 000	50 000	28 000	10 000	30 940	29 286	37 745	275 526	254 510	251 124	138 566	264 452
Deferred Income Tax	0	0	1 195	1 313	0	2 093	0	0	0	0	0	14 494	15 704	15 704	16 209	72	95	0	26 768	28 424	26 550	36 505	38 211	26 550
Minority Interest	580	617	698	783	869	921	83	87	0	0	0	0	0	0	0	0	0	0	103 190	67 608	65 681	33	73	0
Other Liabilities	9 365	9 248	8 061	7 707	18 985	13 790	13 597	13 448	18 259	15 679	16 218	23 646	28 581	36 365	37 312	124 599	115 678	109 119	59 663	77 852	75 005	67 637	59 119	41 520
Total Liabilities	70 846 N/A	71 369 +1%	63 664 -11%	66 776 +5%	105 197 +58%	77 441 -26%	81 591 +5%	66 881 -18%	283 256 +324%	265 879 -6%	240 184 -10%	257 971 +7%	260 492 +1%	260 562 +0%	261 243 +0%	366 804 +40%	356 961 -3%	336 579 -6%	723 864 +115%	727 557 +1%	700 119 -4%	727 993 +4%	751 443 +3%	573 125 -24%
Equity
Common Stock	13 444	13 444	13 444	13 444	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400
Retained Earnings	84 766	89 300	95 579	100 821	232 485	249 481	268 800	281 628	294 701	304 186	305 664	308 556	318 861	326 686	341 401	357 769	396 037	431 799	457 330	508 677	514 210	280 999	22 665	46 784
Additional Paid In Capital	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 860	15 861	17 837	15 855	16 725	0	0	0
Unrealized Security Profit/Loss	1 960	761	8 047	8 031	17 348	17 827	11 690	5 162	7 945	5 413	8 016	14 121	17 247	17 247	0	0	31 735	32 611	46 118	38 575	23 838	39 260	64 526	9 306
Treasury Stock	46	3 321	3 362	3 508	329	479	557	643	646	648	649	651	656	660	0	667	669	674	677	679	681	682	682	682
Other Equity	0	0	0	0	0	0	0	0	3 222	23 228	32 065	11 038	24 828	63 636	42 181	16 906	12 640	3 859	10 338	4 258	31 396	64 772	92 484	91 671
Total Equity	115 984 N/A	116 044 +0%	129 568 +12%	134 648 +4%	287 764 +114%	305 089 +6%	318 193 +4%	324 407 +2%	343 482 +6%	323 983 -6%	319 226 -1%	349 248 +9%	398 540 +14%	451 021 +13%	446 472 -1%	412 268 -8%	452 723 +10%	498 138 +10%	532 670 +7%	580 570 +9%	607 888 +5%	406 749 -33%	156 063 -62%	169 479 +9%
Total Liabilities & Equity	186 830 N/A	187 413 +0%	193 232 +3%	201 424 +4%	392 961 +95%	382 530 -3%	399 784 +5%	391 288 -2%	626 738 +60%	589 862 -6%	559 410 -5%	607 219 +9%	659 032 +9%	711 583 +8%	707 715 -1%	779 072 +10%	809 684 +4%	834 717 +3%	1 256 534 +51%	1 308 127 +4%	1 308 007 0%	1 134 742 -13%	907 506 -20%	742 604 -18%
Shares Outstanding
Common Shares Outstanding	168	165	165	165	398	398	397	397	397	397	397	397	397	397	397	397	397	397	397	397	397	397	397	397

Income Statement Balance Sheet Cash Flow Statement

Sumitomo Pharma Co Ltd
TSE:4506

Balance Sheet

Balance Sheet Decomposition
Sumitomo Pharma Co Ltd

Balance Sheet
Sumitomo Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Sumitomo Pharma Co Ltd TSE:4506

Balance Sheet

Balance Sheet Decomposition Sumitomo Pharma Co Ltd

Balance Sheet Sumitomo Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Sumitomo Pharma Co Ltd
TSE:4506

Balance Sheet Decomposition
Sumitomo Pharma Co Ltd

Balance Sheet
Sumitomo Pharma Co Ltd